Ajanta Pharma Ltd Company Profile
✉ Email this page to a colleague
What is the competitive landscape for AJANTA PHARMA LTD, and what generic and branded alternatives to AJANTA PHARMA LTD drugs are available?
AJANTA PHARMA LTD has sixty-eight approved drugs.
There are three tentative approvals on AJANTA PHARMA LTD drugs.
Summary for Ajanta Pharma Ltd
US Patents: | 0 |
Tradenames: | 57 |
Ingredients: | 56 |
NDAs: | 68 |
Drug Master File Entries: | 2 |
Drugs and US Patents for Ajanta Pharma Ltd
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ajanta Pharma Ltd | GUANFACINE HYDROCHLORIDE | guanfacine hydrochloride | TABLET;ORAL | 217293-001 | Apr 27, 2023 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Ajanta Pharma Ltd | TOPIRAMATE | topiramate | CAPSULE, EXTENDED RELEASE;ORAL | 215663-004 | Aug 15, 2023 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
Ajanta Pharma Ltd | OLANZAPINE | olanzapine | TABLET;ORAL | 206711-003 | Aug 30, 2016 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
Ajanta Pharma Ltd | BREXPIPRAZOLE | brexpiprazole | TABLET;ORAL | 213718-005 | Feb 3, 2023 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
Ajanta Pharma Ltd | AMLODIPINE AND OLMESARTAN MEDOXOMIL | amlodipine besylate; olmesartan medoxomil | TABLET;ORAL | 207216-004 | Oct 28, 2016 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Ajanta Pharma Ltd | RANOLAZINE | ranolazine | TABLET, EXTENDED RELEASE;ORAL | 210054-001 | May 28, 2019 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Ajanta Pharma Ltd | OXYBUTYNIN CHLORIDE | oxybutynin chloride | TABLET, EXTENDED RELEASE;ORAL | 211655-003 | Feb 28, 2019 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.